Dr. Goodenow is Senior Advisor to the Director of the National Institutes of Health (NIH) and Chief and Senior Investigator of the Molecular HIV and Host Interactions Section in the NIH intramural research program within the National Institute of Allergy and Infectious Diseases. From 2016 to 2023, she was the NIH Associate Director for AIDS Research and Director of the Office of AIDS Research (OAR). From 2015 to 2016, she was the Acting Director of the Office for Research and Science within the U.S. Department of State, Office of the U.S. Global AIDS Coordinator and Global Health Diplomacy, where her portfolio included combination HIV prevention trials funded by the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR).
Previously, Dr. Goodenow was Professor of Pathology, Immunology, and Laboratory Medicine at the University of Florida, Gainesville where she was awarded the Stephany W. Holloway University Endowed Chair for AIDS Research. She also was the Director of the Center for Research in Pediatric Immune Deficiency. Her research focuses on HIV molecular epidemiology, immune pathogenesis, inflammation, and vaccines for treatment and cure in pediatric and youth populations. Dr. Goodenow has published over 125 articles and book chapters and trained more than 30 doctoral and postdoctoral fellows. She received her Ph.D. in molecular genetics from the Albert Einstein College of Medicine in New York. Following a postdoctoral fellowship in molecular oncology at the Sloan Kettering Institute in New York, she was a visiting scientist at the Pasteur Institute in Paris, where she began her studies of HIV.
